| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $2.2B | $1.3B | $2.4B | $3.0B | — | — |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | $-0.0B | $-0.0B |
| Net Income | $0.0B | $0.0B | $-0.0B | $0.0B | $0.1B | $-0.0B | $-0.0B |
| EPS (Basic) | $0.13 | $0.13 | $-0.14 | $0.45 | $0.98 | — | — |
| EPS (Diluted) | $0.12 | $0.13 | $-0.14 | $0.45 | $0.66 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $16.9B | $15.7B | $11.9B | $13.6B | $22.5B | $0.4B | $0.0B |
| Current Assets | — | — | — | — | — | $0.0B | $0.0B |
| Cash & Equivalents | $0.5B | $0.5B | $0.5B | $0.7B | $0.7B | $0.0B | $0.0B |
| Total Liabilities | $15.3B | $13.6B | $9.4B | $10.4B | $19.4B | $0.0B | $0.0B |
| Current Liabilities | — | — | — | — | — | $0.0B | $0.0B |
| Stockholders' Equity | — | — | — | — | — | $0.0B | $-0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-2.6B | $-6.2B | $0.2B | $8.3B | $-10.0B | $-0.0B | $-0.0B |
| Investing Cash Flow | $2.3B | $2.7B | $1.8B | $1.3B | $0.2B | $-0.4B | — |
| Capital Expenditures | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | — | — |
| Financing Cash Flow | $0.4B | $3.6B | $-2.2B | $-9.6B | $9.3B | $0.4B | $0.0B |